Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Fresenius will distribute Genzyme's Sepra products in select European markets

Feb. 17, 1999

Health Canada approves first active wound-healing agent

Feb. 16, 1999

AxyS initiates phase Ib studies of APC-2059 in psoriasis

Feb. 16, 1999

Human Genome Sciences initiates phase II clinical trials of new wound-healing agent

Feb. 15, 1999

Pierre Fabre Dermatologie to commercialize Allergan's Zorac in Europe

Feb. 12, 1999

ADCON-L improves clinical outcome following lumbar discectomy

Feb. 11, 1999

Micrologix Biotech continues preclinical testing on acne drugs

Feb. 8, 1999

Schering discloses new leukotriene antagonists particularly useful as dermatological products

Feb. 3, 1999

Gliatech initiates ADCON-P pivotal clinical trial

Jan. 29, 1999

Vertex initiates phase II psoriasis trial of VX-497

Jan. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...